Jane Street Group, LLC Allakos Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$5.08 - $9.81 $267,208 - $516,006	-52,600 Reduced 33.89%	102,600 $585,000
Q4 2021 Feb 15, 2022	BUY	$8.55 - $111.89 $1.1 Million - $14.4 Million	128,700 Added 485.66%	155,200 $1.52 Million
Q3 2021 Nov 16, 2021	SELL	$76.53 - $110.43 $2.62 Million - $3.79 Million	-34,300 Reduced 56.41%	26,500 $2.81 Million
Q2 2020 Aug 17, 2020	BUY	$44.04 - $80.69 $2.68 Million - $4.91 Million	60,800 New	60,800 $4.37 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $98.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.